St Peter's Medical Arts Slingerlands, NY - 12159

St Peter's Medical Arts is categorized under Hospital, Ama Approved Residency in Slingerlands, NY .

St Peter's Medical Arts was established in 0, and today employs 1 to 4, earning $10.000.000 to $19.9999.999 per year. This is a Hospital, Ama Approved Residency business, which does work in the B2C market, and is classified as a Hospital, Ama Approved Residency, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Mary Buono at the company’s single location by writing to 1240 New Scotland Road, Slingerlands, New York NY 12159 or by phoning (518) 475-7000. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: St Peter's Medical Arts
Contact Person: Mary Buono
Address: 1240 New Scotland Road, Slingerlands, New York 12159
Phone Number: (518) 475-7000
Website Address: sphp.com
Annual Revenue (USD): $10.000.000 to $19.9999.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Hospital, Ama Approved Residency
SIC Code: 8062
NAICS Code: 6211110
Share This Business:

St Peter's Medical Arts was started in 0 to provide professional Hospital, Ama Approved Residency under the SIC code 8062 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $10.000.000 to $19.9999.999 per annum.

Feel free to contact Mary Buono for inquiries that concern St Peter's Medical Arts by calling the company number (518) 475-7000, as your correspondence is most welcome. Additionally, the physical location of the single location of St Peter's Medical Arts can be found at the coordinates 42.64612,-73.84898 as well as the street address 1240 New Scotland Road in Slingerlands, New York 12159.

For its online presence, you may visit St Peter's Medical Arts’s website at sphp.com and engage with its social media outlets through on Twitter and on Facebook.